Form 4: Insider Boosts Biodesix Stake with $1.18M Stock Purchases

Jack W. Schuler, a Director and 10% Owner of Biodesix Inc., increased his indirect beneficial ownership by purchasing 100,000 shares of common stock across two transactions in late January 2026.

Summary

• Jack W. Schuler, a Director and 10% Owner of Biodesix Inc. (BDSX), reported recent purchases of the company's common stock.
• On January 23, 2026, Schuler indirectly acquired 80,000 shares of Common Stock at a weighted average price of $11.8084 per share.
• On January 26, 2026, he indirectly acquired an additional 20,000 shares of Common Stock at a weighted average price of $11.8032 per share.
• These purchases were made through the Jack W. Schuler Living Trust, for which he is the sole trustee.
• Following these transactions, the Jack W. Schuler Living Trust beneficially owns 1,563,210 shares.
• Additionally, Jack W. Schuler indirectly owns 750,000 shares through the Jack W. Schuler 2025 GRAT, for which he is also the sole trustee.
• The total beneficial ownership reported by Schuler after these transactions is 2,313,210 shares (1,563,210 + 750,000).
• The transactions were made pursuant to a Rule 10b5-1(c) plan.

Sentiment

Score: 7

Explanation: The insider purchases by a Director and 10% Owner suggest confidence in the company's valuation and future prospects, which is a positive signal for investors.

Positives

• A Director and 10% Owner, Jack W. Schuler, increased his stake in Biodesix Inc. by purchasing 100,000 shares of common stock.
• Insider buying can signal confidence in the company's future prospects and valuation.
• The purchases were executed under a Rule 10b5-1(c) plan, indicating a pre-planned investment strategy.

Future Outlook

NA

Industry Context

NA

Related Party Transactions

• Jack W. Schuler, a Director and 10% Owner, purchased 100,000 shares of common stock through trusts for which he is the sole trustee.

Stakeholder Impact

• Shareholders: May view the insider buying as a positive signal of management confidence, potentially influencing stock price.

Key Dates

Keywords

Biodesix Inc., BDSX, Jack W. Schuler, Insider Trading, Form 4, Stock Purchase, Director, 10% Owner, Equity Acquisition, Rule 10b5-1, Common Stock